LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12279

Search options

  1. Article ; Online: Corrigendum to "Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK/ERK signaling pathway" [Biomed. Pharmacother. 116 (2019) 108967].

    Zhu, Lei / Dai, Lu-Ming / Shen, Hong / Gu, Pei-Qing / Zheng, Kai / Liu, Ya-Jun / Zhang, Lu / Cheng, Jia-Fei

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2023  Volume 163, Page(s) 114854

    Language English
    Publishing date 2023-05-12
    Publishing country France
    Document type Published Erratum
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2023.114854
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Enhanced Effect of Qing-Ying Decoction Concurrent with Secukinumab in the Treatment of Plaque Psoriasis.

    Tian, Zan / Cang, Rong / Lei, Mingjun / Fan, Lifang / Wang, Hua / Shang, Mengyu / Li, Xiang / Bai, Fan

    Alternative therapies in health and medicine

    2022  Volume 28, Issue 6, Page(s) 96–102

    Abstract: Both Qing-Ying decoction (QYD), a Traditional Chinese Medicine (TCM), and secukinumab, a fully ...

    Abstract Both Qing-Ying decoction (QYD), a Traditional Chinese Medicine (TCM), and secukinumab, a fully humanized anti-interleukin-17A monoclonal antibody, have been used to treat patients with plaque psoriasis. The combined application of TCM and biologics in the treatment of psoriasis, however, has not been investigated. We enrolled a total of 68 patients with plaque psoriasis in our prospective study, and randomly assigned them to either the study group (treated with secukinumab plus QYD), or the control group (treated with secukinumab alone). After 12- and 16-week treatment, the Psoriasis Area and Severity Index (PASI) score and the TCM score were significantly reduced in both the study and the control groups. However, the reduction in PASI and TCM scores was more significant in the study group than in the control group (12-week: PASI: 5.29 ± 0.27 vs 8.87 ± 0.38, respectively; P < .01; TCM: 5.83 ± 0.21 vs 12.39 ± 1.23, respectively; P < .01; 16-week: PASI score: 4.76 ± 0.18 vs 8.36 ± 0.31, respectively; TCM score: 4.98 ± 0.19 vs 11.27 ± 1.13, respectively; P < .01). The total treatment efficacy rate was significantly higher in the study group (97.1%) than the control group (76.5%; P = .012). The number of CD3+ and CD4+ T cells was increased, while the number of CD8+ T cells was decreased after treatment in both groups, with more significant changes in the study group (P < .01). QYD may enhance the therapeutic outcome of secukinumab in the treatment of plaque psoriasis by further suppressing chronic skin inflammation, as well as reducing adverse events and patients' psychological stress.
    MeSH term(s) Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Prospective Studies ; Psoriasis/drug therapy ; Treatment Outcome
    Chemical Substances Antibodies, Monoclonal, Humanized ; secukinumab (DLG4EML025)
    Language English
    Publishing date 2022-06-10
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1225073-9
    ISSN 1078-6791
    ISSN 1078-6791
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Skin diseases in the Da Qing Diabetes Study: a cross-sectional study.

    Shen, Chang-Bing / Qian, Xin / Yu, Rui-Xing / Ji, Xue-Lei / Shi, Yin-Juan / Gao, Jing / Li, Cheng-Xu / Li, Ke-Ke / Fei, Wen-Min / Shen, Xue / Wang, Zi-Yi / Han, Yang / Ning, Xiao-Li / Ko, Randy / Hsu, Yi-Hsiang / Yin, Xian-Yong / Li, Guang-Wei / Cui, Yong

    Chinese medical journal

    2021  Volume 134, Issue 10, Page(s) 1191–1198

    Abstract: ... and T2DM.: Methods: We collected 383 subjects from the Da Qing Diabetes Study during the period ... of skin diseases in the Da Qing Diabetes Study. To address the skin diseases in the Da Qing Diabetes Study ...

    Abstract Background: The prevalence of skin diseases and diabetes mellitus (DM) are prominent around the world. The current scope of knowledge regarding the prevalence of skin diseases and comorbidities with type 2 DM (T2DM) is limited, leading to limited recognition of the correlations between skin diseases and T2DM.
    Methods: We collected 383 subjects from the Da Qing Diabetes Study during the period from July 9th to September 1st, 2016. The subjects were categorized into three groups: Normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM. The prevalence and clinical characteristics of skin diseases were recorded and investigated.
    Results: In this cross-sectional study, 383 individuals with ages ranging from 53 to 89-year-old were recruited. The overall prevalence of skin diseases was 93.5%, and 75.7% of individuals had two or more kinds of skin diseases. Additionally, there were 47 kinds of comorbid skin diseases in patients with T2DM, of which eight kinds of skin diseases had a prevalence >10%. The prevalence of skin diseases in NGT, IGT, and T2DM groups were 93.3%, 91.5%, and 96.6%, respectively; stratified analysis by categories showed a statistically significant difference in "disturbances of pigmentation" and "neurological and psychogenic dermatoses". The duration of T2DM also significantly associated with the prevalence of "disturbances of pigmentation" and "neurological and psychogenic dermatoses". Subsequently, the prevalence of "disturbances of pigmentation" was higher in males than females in NGT (P < 0.01) and T2DM (P < 0.01) groups. In addition, the difference in the prevalence of "disturbances of pigmentation" was also significant in NGT and T2DM groups (P < 0.01).
    Conclusions: There was a high prevalence of skin diseases in the Da Qing Diabetes Study. To address the skin diseases in the Da Qing Diabetes Study, increased awareness and intervention measures should be implemented.
    MeSH term(s) Aged ; Aged, 80 and over ; Blood Glucose ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Glucose Intolerance/epidemiology ; Glucose Tolerance Test ; Humans ; Male ; Middle Aged ; Skin Diseases/epidemiology
    Chemical Substances Blood Glucose
    Language English
    Publishing date 2021-04-14
    Publishing country China
    Document type Journal Article
    ZDB-ID 127089-8
    ISSN 2542-5641 ; 0366-6999 ; 1002-0187
    ISSN (online) 2542-5641
    ISSN 0366-6999 ; 1002-0187
    DOI 10.1097/CM9.0000000000001453
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Corrigendum to "Fei-Yan-Qing-Hua decoction decreases hyperinflammation by inhibiting HMGB1/RAGE signaling and promotes bacterial phagocytosis in the treatment of sepsis" [J. Ethnopharmacol. (2024 Mar 1) 321:117553].

    Zhang, Huan / Xu, Guihua / Wu, Xiao / Xu, Yanwu / Xu, Lirong / Zou, Yingxiang / Yang, Xiaodong / Pan, Lingyun / Lei, Biao / Mu, Jingwen / Huang, Qilin / Ma, Yuhe / Duan, Naifan / Zhang, Wei / Zheng, Yuejuan

    Journal of ethnopharmacology

    2024  Volume 326, Page(s) 117978

    Language English
    Publishing date 2024-03-05
    Publishing country Ireland
    Document type Published Erratum
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2024.117978
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Skin diseases in the Da Qing Diabetes Study

    Chang-Bing Shen / Xin Qian / Rui-Xing Yu / Xue-Lei Ji / Yin-Juan Shi / Jing Gao / Cheng-Xu Li / Ke-Ke Li / Wen-Min Fei / Xue Shen / Zi-Yi Wang / Yang Han / Xiao-Li Ning / Randy Ko / Yi-Hsiang Hsu / Xian-Yong Yin / Guang-Wei Li / Yong Cui / Li-Shao Guo

    Chinese Medical Journal, Vol 134, Iss 10, Pp 1191-

    a cross-sectional study

    2021  Volume 1198

    Abstract: ... and T2DM. Methods:. We collected 383 subjects from the Da Qing Diabetes Study during the period ... diseases in the Da Qing Diabetes Study. To address the skin diseases in the Da Qing Diabetes Study ...

    Abstract Abstract. Background:. The prevalence of skin diseases and diabetes mellitus (DM) are prominent around the world. The current scope of knowledge regarding the prevalence of skin diseases and comorbidities with type 2 DM (T2DM) is limited, leading to limited recognition of the correlations between skin diseases and T2DM. Methods:. We collected 383 subjects from the Da Qing Diabetes Study during the period from July 9th to September 1st, 2016. The subjects were categorized into three groups: Normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM. The prevalence and clinical characteristics of skin diseases were recorded and investigated. Results:. In this cross-sectional study, 383 individuals with ages ranging from 53 to 89-year-old were recruited. The overall prevalence of skin diseases was 93.5%, and 75.7% of individuals had two or more kinds of skin diseases. Additionally, there were 47 kinds of comorbid skin diseases in patients with T2DM, of which eight kinds of skin diseases had a prevalence >10%. The prevalence of skin diseases in NGT, IGT, and T2DM groups were 93.3%, 91.5%, and 96.6%, respectively; stratified analysis by categories showed a statistically significant difference in “disturbances of pigmentation” and “neurological and psychogenic dermatoses”. The duration of T2DM also significantly associated with the prevalence of “disturbances of pigmentation” and “neurological and psychogenic dermatoses”. Subsequently, the prevalence of “disturbances of pigmentation” was higher in males than females in NGT (P < 0.01) and T2DM (P < 0.01) groups. In addition, the difference in the prevalence of “disturbances of pigmentation” was also significant in NGT and T2DM groups (P < 0.01). Conclusions:. There was a high prevalence of skin diseases in the Da Qing Diabetes Study. To address the skin diseases in the Da Qing Diabetes Study, increased awareness and intervention measures should be implemented.
    Keywords Medicine ; R
    Subject code 571
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Wolters Kluwer
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Fei-Yan-Qing-Hua decoction decreases hyperinflammation by inhibiting HMGB1/RAGE signaling and promotes bacterial phagocytosis in the treatment of sepsis.

    Zhang, Huan / Xu, Guihua / Wu, Xiao / Xu, Yanwu / Xu, Lirong / Zou, Yingxiang / Yang, Xiaodong / Pan, Lingyun / Lei, Biao / Mu, Jingwen / Huang, Qilin / Ma, Yuhe / Duan, Naifan / Zhang, Wei / Zheng, Yuejuan

    Journal of ethnopharmacology

    2023  Volume 321, Page(s) 117553

    Abstract: Ethnopharmacological relevance: Fei-Yan-Qing-Hua decoction (FYQHD), derived from the renowned ...

    Abstract Ethnopharmacological relevance: Fei-Yan-Qing-Hua decoction (FYQHD), derived from the renowned formula Ma Xing Shi Gan tang documented in Zhang Zhong Jing's "Treatise on Exogenous Febrile Disease" during the Han Dynasty, has demonstrated notable efficacy in the clinical treatment of pneumonia resulting from bacterial infection. However, its molecular mechanisms underlying the therapeutic effects remains elusive.
    Aim of the study: This study aimed to investigate the protective effects of FYQHD against lipopolysaccharide (LPS) and carbapenem-resistant Klebsiella pneumoniae (CRKP)-induced sepsis in mice and to elucidate its specific mechanism of action.
    Materials and methods: Sepsis models were established in mice through intraperitoneal injection of LPS or CRKP. FYQHD was administered via gavage at low and high doses. Serum cytokines, bacterial load, and pathological damage were assessed using enzyme-linked immunosorbent assay (ELISA), minimal inhibitory concentration (MIC) detection, and hematoxylin and eosin staining (H&E), respectively. In vitro, the immunoregulatory effects of FYQHD on macrophages were investigated through ELISA, MIC, quantitative real-time PCR (Q-PCR), immunofluorescence, Western blot, and a network pharmacological approach.
    Results: The application of FYQHD in the treatment of LPS or CRKP-induced septic mouse models revealed significant outcomes. FYQHD increased the survival rate of mice exposed to a lethal dose of LPS to 33.3%, prevented hypothermia (with a rise of 3.58 °C), reduced pro-inflammatory variables (including TNF-α, IL-6, and MCP-1), and mitigated tissue damage in LPS or CRKP-induced septic mice. Additionally, FYQHD decreased bacterial load in CRKP-infected mice. In vitro, FYQHD suppressed the expression of inflammatory cytokines in macrophages activated by LPS or HK-CRKP. Mechanistically, FYQHD inhibited the PI3K/AKT/mTOR/4E-BP1 signaling pathway, thereby suppressing the translational level of inflammatory cytokines. Furthermore, it reduced the expression of HMGB1/RAGE, a positive feedback loop in the inflammatory response. Moreover, FYQHD was found to enhance the phagocytic activity of macrophages by upregulating the expression of phagocytic receptors such as CD169 and SR-A1.
    Conclusion: FYQHD provides protection against bacterial sepsis by concurrently inhibiting the inflammatory response and augmenting the phagocytic ability of immune cells.
    MeSH term(s) Mice ; Animals ; Lipopolysaccharides/pharmacology ; HMGB1 Protein/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Signal Transduction ; Cytokines/metabolism ; Phagocytosis ; Sepsis/drug therapy
    Chemical Substances Lipopolysaccharides ; HMGB1 Protein ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; Cytokines
    Language English
    Publishing date 2023-12-06
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.117553
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study.

    Hu, Wanxia / Xu, Wenhua / Si, Lei / Wang, Cuilian / Jiang, Qicheng / Wang, Lidan / Cutler, Henry

    PloS one

    2020  Volume 15, Issue 12, Page(s) e0242962

    Abstract: Objective: The Da Qing Diabetes Prevention program (DQDP) was a randomized lifestyle modification ... by the hazard ratio of cardiovascular disease event.: Conclusions: The Da Qing lifestyle intervention ...

    Abstract Objective: The Da Qing Diabetes Prevention program (DQDP) was a randomized lifestyle modification intervention conducted in 1986 for the prevention and control of type 2 diabetes in individuals with impaired glucose tolerance. The current study estimated long-term cost-effectiveness of the program based on the health utilities from the Chinese population.
    Methods: A Markov Monte Carlo model was developed to estimate the impact of the intervention from the healthcare system perspective. The analysis was run over 30-year and lifetime periods and costs were estimated respectively as health management service costs. Baseline characteristics and intervention effects were assessed from the DQDP. Utilities and costs were generated from relevant literature. The outcome measures were program cost per quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio (ICER) of the intervention. Sensitivity analyses and threshold analyses were performed.
    Results: Using a 30-year horizon, the intervention strategy was cost-saving and was associated with better health outcomes (increase of 0.74 QALYs per intervention participant). Using a lifetime horizon, the intervention strategy was cost-saving and was associated with additional 1.44 QALYs. Sensitivity analyses showed that the overall ICER was most strongly influenced by the hazard ratio of cardiovascular disease event.
    Conclusions: The Da Qing lifestyle intervention in a Chinese population with impaired glucose tolerance is likely to translate into substantial economic value. It is cost-saving over a 30-year time and lifetime frame.
    MeSH term(s) Adult ; Cost-Benefit Analysis ; Diabetes Mellitus, Type 2/prevention & control ; Female ; Humans ; Life Style ; Male ; Markov Chains ; Middle Aged ; Monte Carlo Method ; Outcome Assessment, Health Care ; Primary Prevention/economics
    Language English
    Publishing date 2020-12-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0242962
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cost-effectiveness of the Da Qing diabetes prevention program

    Wanxia Hu / Wenhua Xu / Lei Si / Cuilian Wang / Qicheng Jiang / Lidan Wang / Henry Cutler

    PLoS ONE, Vol 15, Iss 12, p e

    A modelling study.

    2020  Volume 0242962

    Abstract: Objective The Da Qing Diabetes Prevention program (DQDP) was a randomized lifestyle modification ... by the hazard ratio of cardiovascular disease event. Conclusions The Da Qing lifestyle intervention in a Chinese ...

    Abstract Objective The Da Qing Diabetes Prevention program (DQDP) was a randomized lifestyle modification intervention conducted in 1986 for the prevention and control of type 2 diabetes in individuals with impaired glucose tolerance. The current study estimated long-term cost-effectiveness of the program based on the health utilities from the Chinese population. Methods A Markov Monte Carlo model was developed to estimate the impact of the intervention from the healthcare system perspective. The analysis was run over 30-year and lifetime periods and costs were estimated respectively as health management service costs. Baseline characteristics and intervention effects were assessed from the DQDP. Utilities and costs were generated from relevant literature. The outcome measures were program cost per quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio (ICER) of the intervention. Sensitivity analyses and threshold analyses were performed. Results Using a 30-year horizon, the intervention strategy was cost-saving and was associated with better health outcomes (increase of 0.74 QALYs per intervention participant). Using a lifetime horizon, the intervention strategy was cost-saving and was associated with additional 1.44 QALYs. Sensitivity analyses showed that the overall ICER was most strongly influenced by the hazard ratio of cardiovascular disease event. Conclusions The Da Qing lifestyle intervention in a Chinese population with impaired glucose tolerance is likely to translate into substantial economic value. It is cost-saving over a 30-year time and lifetime frame.
    Keywords Medicine ; R ; Science ; Q
    Subject code 796 ; 360
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Qing-Chang-Hua-Shi granule ameliorates DSS-induced colitis by activating NLRP6 signaling and regulating Th17/Treg balance.

    Cheng, Cheng / Hu, Jingyi / Li, Yanan / Ji, Yuejin / Lian, Ziyu / Au, Ryan / Xu, Feng / Li, Weiyang / Shen, Hong / Zhu, Lei

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2022  Volume 107, Page(s) 154452

    Abstract: Background: Chinese herbal medicine Qing-Chang-Hua-Shi granule (QCHS) is widely used to treat ...

    Abstract Background: Chinese herbal medicine Qing-Chang-Hua-Shi granule (QCHS) is widely used to treat ulcerative colitis in China. However, the molecular mechanisms of QCHS remains largely unknown.
    Purpose: To assess the therapeutic effects of QCHS on colitis and to reveal its mechanisms of action.
    Methods: The main components of QCHS were identified using a UHPLC-QTOF-MS method and the efficacy of QCHS was evaluated using an DSS-induced mice model. The inflammatory responses and mucosal integrity in colon were comprehensively assessed. Flow cytometry was used to analysis the proportion of Th17 and Treg cells. Detect the signal transduction of the NOD-like receptor family pyrin domain containing 6 (NLRP6) both in vitro and in vivo. Furthermore, siNLRP6 transfection was used to validate the functional targets of QCHS.
    Results: QCHS treatment significantly alleviated colitis in mice by improving symptoms and pathological damage. Moreover, QCHS treatment suppressed the inflammatory response and preserved the integrity of colon tissue. Most importantly, QCHS balanced the Th17/Treg response of UC mice. Mechanistically, by activating NLRP6 inflammasome pathway, QCHS regulated the maturation of interleukin (IL)-1β and IL-18 to affect inflammation and drive Th17 cell differentiation.
    Conclusions: The effect of QCHS on UC mice is dose-dependent, with high-dose QCHS being superior to 5-Aminosalicylic acid (200 mg/kg/day). QCHS acts through the NLRP6 signaling pathway to modulate Th17/Treg balance, resulting in the protective effects against colitis. This study investigated the relevant pharmacological mechanisms of QCHS, providing further evidence for the application of QCHS in UC treatment.
    MeSH term(s) Animals ; Colitis/chemically induced ; Colitis/drug therapy ; Colitis/metabolism ; Colitis, Ulcerative/chemically induced ; Colitis, Ulcerative/drug therapy ; Colitis, Ulcerative/pathology ; Colon/pathology ; Dextran Sulfate/adverse effects ; Drugs, Chinese Herbal/therapeutic use ; Inflammasomes/metabolism ; Interleukin-18/metabolism ; Interleukin-18/pharmacology ; Interleukin-18/therapeutic use ; Mesalamine/adverse effects ; Mice ; Mice, Inbred C57BL ; NLR Proteins/metabolism ; Signal Transduction ; T-Lymphocytes, Regulatory ; Th17 Cells
    Chemical Substances Drugs, Chinese Herbal ; Inflammasomes ; Interleukin-18 ; NLR Proteins ; qing-chang-hua-shi granules ; Mesalamine (4Q81I59GXC) ; Dextran Sulfate (9042-14-2)
    Language English
    Publishing date 2022-09-13
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2022.154452
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK/ERK signaling pathway.

    Zhu, Lei / Dai, Lu-Ming / Shen, Hong / Gu, Pei-Qing / Zheng, Kai / Liu, Ya-Jun / Zhang, Lu / Cheng, Jia-Fei

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2019  Volume 116, Page(s) 108967

    Abstract: Ulcerative colitis (UC), a bowel disease with significant morbidity, is associated with inflammation. In this study, the effect of Qingchang Huashi granule (QCHS) on UC and its underlying mechanisms were explored using both animal and cell culture ... ...

    Abstract Ulcerative colitis (UC), a bowel disease with significant morbidity, is associated with inflammation. In this study, the effect of Qingchang Huashi granule (QCHS) on UC and its underlying mechanisms were explored using both animal and cell culture experiments. A rat UC model was induced with trinitro-benzene-sulfonic acid (TNBS), concentrations of the cytokines IL-1α, IL-6, IL-8, IL-1β, and TNF-α were significantly up-regulated and the concentrations of IL-4, IL-10, and IL-13 were significantly down-regulated compared with the control group (P < 0.05). In contrast, the QCHS and salicylazosulfapyridine (SASP) groups reversed these modulations (P < 0.05). A UC cell model in HT-29 cells was generated using TNF-α combined with lipopolysaccharide treatment. Cells treated with QCHS were used to investigate the possible mechanisms. The expression of apoptosis-related proteins, including Bax/Bcl-2, caspase-3, caspase-9, Fas/Fas-L, and Rafl in the QCHS and SASP groups, were significantly lower than that in the control group in both animal and cell experiments (P < 0.05). In addition, the in vitro results indicate changes in these indicators mediate the MEK/ERK signaling pathways via SGK1. Our results suggested that QCHS could be beneficial in preventing UC progression as an alternative drug for UC treatment.
    MeSH term(s) Animals ; Apoptosis/drug effects ; Biomarkers/metabolism ; Colitis, Ulcerative/drug therapy ; Colitis, Ulcerative/enzymology ; Colitis, Ulcerative/pathology ; Colon/drug effects ; Colon/pathology ; Cytokines/metabolism ; Disease Models, Animal ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Female ; Gene Silencing ; HT29 Cells ; Humans ; Immediate-Early Proteins/metabolism ; Inflammation/pathology ; Lipopolysaccharides ; MAP Kinase Signaling System/drug effects ; Male ; Models, Biological ; Protein Serine-Threonine Kinases/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Rats, Sprague-Dawley
    Chemical Substances Biomarkers ; Cytokines ; Drugs, Chinese Herbal ; Immediate-Early Proteins ; Lipopolysaccharides ; RNA, Messenger ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; serum-glucocorticoid regulated kinase (EC 2.7.11.1)
    Language English
    Publishing date 2019-05-16
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2019.108967
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top